Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharm-country save search
Medicare Coverage Significantly Expanded for the Eversense E3 CGM System - February 12, 2024
Published: 2024-02-12 (Crawled : 14:30) - biospace.com/
SENS | $0.43 7.82% 0.12% 1.6M
|
Electronic Technology
|
| O: 0.2%
H: 10.25%
C: 7.24%
eversense system
Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
Published: 2024-02-08 (Crawled : 00:00) - biospace.com/
APDN | $0.2888 -12.49% -14.27% 810K
|
Commercial Services
|
| O: 5.0%
H: 0.02%
C: -4.76%
first year dna financial results
Insmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024
Published: 2024-02-08 (Crawled : 00:00) - biospace.com/
INSM | $25.25 4.73% 4.51% 2.1M
|
Health Technology
|
| O: -0.17%
H: 0.21%
C: -1.28%
conference year financial results
Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors
Published: 2024-02-08 (Crawled : 13:30) - biospace.com/
LUCD | $0.718 -4.37% -4.57% 270K
|
|
| O: 0.0%
H: 1.44%
C: -3.79%
PAVM | $1.85 -1.6% -1.62% 27K
|
Health Technology
|
| O: 4.02%
H: 2.21%
C: -7.18%
esoguard contract diagnostics
INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Published: 2024-02-07 (Crawled : 00:00) - biospace.com/
INO | $10.34 3.19% 3.09% 240K
|
Health Technology
|
| O: -0.94%
H: 4.69%
C: 0.76%
conference life sciences
Bristol Myers Squibb Announces Acceptance of U.S. and EU Regulatory Filings for Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo in Resectable Non-Small Cell Lung Cancer
Published: 2024-02-07 (Crawled : 13:30) - biospace.com/
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: -0.14%
H: 0.35%
C: -1.12%
lung opdivo cancer cell
The Cigna Group Announces Commencement of Tender Offers for up to $2.25 Billion in Aggregate Principal Amount of Outstanding Notes
Published: 2024-02-05 (Crawled : 15:00) - biospace.com/
CI | $352.65 -0.15% 0.0% 940K
|
Health Services
|
| O: 1.09%
H: 1.05%
C: -1.86%
group
Shionogi Strengthens Regulatory Leadership with the Appointment of Dr. Ramón Polo as Senior Vice President, Head of Regulatory Affairs
Published: 2024-02-05 (Crawled : 15:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
Hyperfine, Inc. Celebrates Breadth of Swoop® System Data Presented at the 2024 International Stroke Conference and Provides an Update on Enrollment in ACTION PMR Stroke Observational Study
Published: 2024-02-01 (Crawled : 21:00) - biospace.com/
HYPR | $0.849 -0.12% -0.12% 130K
|
Manufacturing
|
| O: 3.74%
H: 0.0%
C: -2.7%
swoop conference stroke update international system study
Delcath Systems Receives Permanent J-Code (J9248) for HEPZATO™ (melphalan/Hepatic Delivery System) Effective April 1, 2024
Published: 2024-01-31 (Crawled : 21:00) - biospace.com/
DCTH | $5.59 1.45% 1.43% 220K
|
Health Technology
|
| O: 6.98%
H: 8.42%
C: 0.84%
The Cigna Group to Host Investor Day in New York City on March 7
Published: 2024-01-31 (Crawled : 14:30) - biospace.com/
CI | $352.65 -0.15% 0.0% 940K
|
Health Services
|
| O: 0.4%
H: 0.97%
C: 0.27%
day group city
Savara to Present at Two Upcoming Healthcare Conferences
Published: 2024-01-31 (Crawled : 14:30) - biospace.com/
SVRA | $4.675 -0.53% -0.53% 500K
|
Health Technology
|
| O: -0.2%
H: 2.28%
C: -1.98%
UroGen Initiates Submission of a Rolling NDA to the FDA for UGN-102
Published: 2024-01-24 (Crawled : 14:30) - biospace.com/
URGN | $14.51 0.97% 0.96% 220K
|
Health Technology
|
| O: 4.24%
H: 0.0%
C: -4.51%
ugn-102 fda submission
Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology Portfolio
Published: 2024-01-23 (Crawled : 14:30) - biospace.com/
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: -0.07%
H: 1.38%
C: 1.25%
EVR | $196.1 2.09% 0.0% 510K
|
Finance
|
| O: 0.35%
H: 0.29%
C: -0.26%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 0.22%
H: 1.49%
C: 0.89%
acquisition
Petros Pharmaceuticals Demonstrates Positive Results Following Successful Completion of Initial Cohort of Phase 2 Equivalent Self-Selection Study for STENDRA (avanafil) Rx-to-OTC Switch
Published: 2024-01-17 (Crawled : 14:30) - biospace.com/
PTPI | $0.68 4.58% 4.38% 610K
|
|
| O: 21.31%
H: 5.41%
C: -19.59%
stendra positive pharmaceuticals results study
Amneal Launches Complex Generic Fluorometholone Ophthalmic Suspension
Published: 2024-01-10 (Crawled : 14:30) - biospace.com/
AMRX | $5.4 0.56% 0.56% 1.4M
|
Health Technology
|
| O: 0.0%
H: 0.7%
C: -3.16%
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors
Published: 2024-01-08 (Crawled : 00:00) - biospace.com/
NUVB | $2.68 0.0% 880K
|
|
| O: 0.67%
H: 4.0%
C: 3.33%
nuv-1511 fda drug tumors treatment clearance application advanced
European Commission Approves Pfizer’s TALZENNA® in Combination with XTANDI® for Adult Patients with Metastatic Castration-Resistant Prostate Cancer
Published: 2024-01-08 (Crawled : 18:00) - biospace.com/
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.37%
H: 1.09%
C: 0.75%
talzenna cancer
PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-08 (Crawled : 16:00) - biospace.com/
PTCT | News S | $25.38 -2.27% -2.32% 750K
|
Health Technology
|
| O: -0.32%
H: 7.87%
C: 7.84%
conference update pipeline commercial therapeutics
MindMed Announces Business Update and Anticipated Milestones for 2024
Published: 2024-01-08 (Crawled : 14:00) - biospace.com/
MNMD | $8.885 2.36% 2.31% 1.2M
|
n/a
|
| O: 0.98%
H: 7.51%
C: 6.3%
business update
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.